45 people showed up at the last episode of the Precision Medicine Series. This episode centered on the status quo and challenges faced by the industry and the regulator from the regulatory and legal perspective, worldwide and in Hong Kong, as the trend of precision medicine arrives.
Riding on the solid partnership with stakeholders, 2018 has been a fruitful year for HKAPI. Our President Caroline Johnson addressed in the AGM that HKAPI has accelerated the momentum and driven policy changes.
Extraordinary General Meeting & CEO Meeting On 2 November 2018, an EGM was called to pass resolutions to adopt the new Code of Practice and Constitution. Key changes of the […]
Members of the Hong Kong Association of the Pharmaceutical Industry met on May 31, 2018 to discuss future plans and development goals as formation of new HKAPI task forces under the auspices of the newly-elected Board of Directors is in full swing.
New Board of Directors Elected at 2018 AGM HKAPI’s new Board of Directors was elected at the 2018 Annual General Meeting (AGM) held on 26 March, 2018. Ms Caroline Johnson, […]
Veteran journalist Chris Yeung told HKAPI members in a public affairs workshop on October 25, 2017 that Hong Kong politics is getting more complicated, as the government and many stakeholders have to take the China factor into consideration when making key decisions.
President Andy Barnett embraced the new approach following our 49th Annual General Meeting on March 20th to build a stronger collaboration in the changing operating environment.